SWM
SLS icon

Scissortail Wealth Management’s SELLAS Life Sciences SLS Stock Holding History

Scissortail Wealth Management’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$462K Buy
31,322
+4,000
+15% +$27.6K 0.09% 81
2026
Q1 		$116K Hold
27,322
– – 0.02% 115
2025
Q4 		$103K Hold
27,322
– – 0.02% 107
2025
Q3 		$44K Buy
+27,322
New +$48.7K 0.01% 116

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Scissortail Wealth Management's SLS Position: Q2 2026 in Review

Scissortail Wealth Management increased its SELLAS Life Sciences (SLS) stake by 15% in Q2 2026, buying an estimated $27.6K and bringing the position to 31,322 shares worth $462K. The position accounts for 0.09% of the portfolio, ranked #81.

Scissortail Wealth Management first reported a position in SLS in Q3 2025 and has held it in 4 quarters since. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Scissortail Wealth Management held 31,322 shares of SELLAS Life Sciences worth $462K as of Q2 2026.
  • Scissortail Wealth Management bought 4,000 SELLAS Life Sciences shares in Q2 2026, an estimated $27.6K.
  • SELLAS Life Sciences made up 0.09% of Scissortail Wealth Management's portfolio in Q2 2026, its #81 holding.
  • Scissortail Wealth Management first reported a position in SELLAS Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Scissortail Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.